Ignite Creation Date:
2025-12-25 @ 12:55 AM
Ignite Modification Date:
2026-05-29 @ 4:22 PM
Study NCT ID:
NCT05446467
Status:
RECRUITING
Last Update Posted:
2025-08-20
First Post:
2022-06-30
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Pembrolizumab in Combination With Low-dose PFas Neoadjuvant Treatment for Locally Advanced HNSCC
Sponsor:
Zhejiang Provincial People's Hospital
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Head and Neck Squamous Cell Carcinoma | View |
Keywords: